Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Curis Inc CRIS

Sector: Healthcare | Sub-Sector: Biotechnology

Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Price: $1.94 Volume: 2.1m
Change: +$0.27 % Change: +16.17%
Day High/Low: 1.95/1.70 52 Week High/Low: 3.40/1.09
Last Traded: January 26, 2015 11:00 Transaction Volume: 1198
Open: 1.70 Previous Close: 1.67
Bid: 1.59 Ask: 2.06
Bid Size: 300 Ask Size: 4000
Market Cap: 166.8m Shares Out: 86.0m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts